Mouwasat Medical Services Company Financials

Market Capitalization SR18.30 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.81
Forward PE	20.84
Price to Sales TTM	SR6.32
Price to Book MRQ	SR5.63
Enterprise to Revenue	6.67
Enterprise to EBITDA	20.03

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	22.72%
Operating Margin	22.33%
Return on Assets TTM	13.25%
Return on Equity TTM	19.19%

Income Statement

Revenue TTM	SR2,896,886,272
Revenue per Share TTM	SR14.49
Quarterly Revenue Growth	10.90%
Gross Profit TTM	SR1,313,079,238
EBITDA	SR1,064,598,183
Net Income to Common TTM	SR658,087,808
Diluted EPS TTM	SR3.29
Quarterly Earnings Growth YoY	-4.30%

Balance Sheet

Total Cash MRQ	SR190,841,152
Total Cash per Share MRQ	SR0.95
Total Debt MRQ	SR
Total Debt to Equity MRQ	26.03
Current Ratio MRQ	1.86
Book Value per Share MRQ	SR16.26

Cash Flow

Operating Cash Flow TTM	SR958,037,056
Levered Free Cash Flow TTM	SR657,687,906

4002 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	200,000,000
Float Shares	94,938,000
Avg 10 Volume	437,358
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	52.50%
% Held by Institutions	6.72%

Stock Price Summary

Beta	0.45
Fifty Two Week Low	SR83.50
Fifty Two Week High	SR144.00
Fifty Two Week Change	-35.56%
Day 50 MA	SR94.00
Day 200 MA	SR112.56

Dividends and Splits

Forward Annual Dividend Rate	SR7.00
Forward Annual Dividend Yield	7.78%
Trailing Annual Dividend Rate	SR1.75
Trailing Annual Dividend Yield	1.94%
Payout Ratio	53.19%
Dividend Date
Ex Dividend Date	2024-05-28
Last Split Factor
Last Split Date	2023-08-08